Surgical treatment of osteomyelitis
- PMID: 21200291
- DOI: 10.1097/PRS.0b013e3182025070
Surgical treatment of osteomyelitis
Abstract
Chronic osteomyelitis is refractory to nonsurgical treatment due to a resilient, infective nidus that harbors sessile, matrix-protected pathogens bound to substrate surfaces within the wound. Curative treatment mandates physical (surgical) removal of the biofilm colony, adjunctive use of antibiotics to eliminate residual phenotypes, and efforts to optimize the host response throughout therapy. Patient selection, therapeutic options, and the treatment format are determined by the Cierny/Mader staging system, while reconstruction is governed by the integrity/stability of the affected bone(s) and quality/quantity parameters of the soft-tissue envelope.
References
-
- Gristina AG. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987;237:1588–1595.
-
- Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108.
-
- Cierny G III, Mader JT. The surgical treatment of adult osteomyelitis. In: Evarts C, McCollister MD, eds. Surgery of the Musculoskeletal System. 1st ed. New York, NY: Churchill Livingstone; 1983:4814–4834.
-
- Simpson AH, Deakin M, Latham JM. Chronic osteomyelitis: The effect of the extent of surgical resection on infection-free survival. J Bone Joint Surg Br. 2001;83:403–407.
-
- Damholt VV. Treatment of chronic osteomyelitis: A prospective study of 55 cases treated with radical surgery and primary wound closure. Acta Orthop Scand. 1982;53:715–720.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
